Patrick Temple-WestJul 26, 2026 – 4.59pmNew York | Businesses tied to Robert F. Kennedy Jr’s Make America Healthy Again movement are poised to benefit from a regulatory overhaul in Washington, as companies aligned with his agenda emerge as its earliest winners.At a two-day meeting at the US Food and Drug Administration last week, a Kennedy-backed advisory panel voted to broaden public access to a handful of drugs known as peptides, despite the agency’s scientific staff advising against it.Financial TimesSubscribe to gift this articleGift 5 articles to anyone you choose each month when you subscribe.Subscribe nowAlready a subscriber? Fetching latest articles